KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Glacier Aminos: 78 Kovera certificates.
The lab's record shows 78 certificates printed for Glacier Aminos, analysed between 19 Feb 2026 and 20 Jun 2026, covering 45 products. Median HPLC purity is 99.92%. Kovera graded 72 as a pass and 3 as a fail; 3 carry no verdict.
78
certificates
99.92%
median purity
45
products
3
lab verdict: fail
3
failure rules met
What the record shows
RETRIEVED 2 AUGUST 20263 of the 78 certificates meet at least one of our failure rules. They are shaded in the table below. 35 measured more than 110% of the label, which Kovera does not grade as a fail.
Kovera revised 5 of these certificates after first publication, under the same report number: KVR-2026-9FA824 (revised by the lab 2026-06-20: purity 99.699% → 99.7%, content 482.24 → — mg); KVR-2026-DE4C22 (revised by the lab 2026-06-08, figures unchanged); KVR-2026-1DA3D4 (revised by the lab 2026-06-08, figures unchanged); KVR-2026-2E9DC5 (revised by the lab 2026-05-31, figures unchanged); KVR-2026-046AFE (revised by the lab 2026-05-31, figures unchanged). Why that matters is in our revisions analysis.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
45 AS PRINTEDGLP3-R · 6GHK-Cu · 4GLP2-T · 45-Amino-1MQ · 3BPC-157 · 3GLA-3 RT · 3Tesamorelin · 3Bacteriostatic Water · 2BPC-157/TB-500 · 2Cagrilintide · 2CJC-1295 (No DAC)/Ipamorelin · 2GLP1-S · 2Glutathione · 2Ipamorelin · 2Melanotan-1 · 2NAD+ · 2PT-141 · 2Selank · 2Semax · 2SLU-PP-332 · 2AHK-Cu · 1AOD-9604 · 1ARA-290 · 1Cartalax · 1DSIP · 1Epithalon · 1GHKPV · 1Glow · 1Kisspeptin-10 · 1Klow · 1KPV · 1Melanotan-2 · 1Methylene Blue (Capsule) · 1MOTS-c · 1MOTS-C · 1MTP-31 · 1Retatrutide · 1Retatrutide/Cagrilintide · 1S-31-S · 1Semax/Selank · 1Sermorelin · 1SS-31 · 1TB-500 (Thymosin B4) · 1Tesamorelin/Ipamorelin · 1Testagen · 1
Every certificate
NEWEST FIRST · 78 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-9FA824 | NAD+ | NADGA-05 | 99.7% | 95.0%475.15 of 500 mg | 20 Jun 2026 | PASSrevised by the lab 2026-06-20: purity 99.699% → 99.7%, content 482.24 → — mg | Kovera ↗our verifier → |
| KVR-2026-DE4C22 | SLU-PP-332 | SLU20CAP-01 | 98.96% | 111.0%22.19 of 20 mg | 7 Jun 2026 | PASSover 110% of labelrevised by the lab 2026-06-08, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-1DA3D4 | 5-Amino-1MQ | 5A50CAP-01 | 98.843% | 115.6%57.81 of 50 mg | 7 Jun 2026 | PASSover 110% of labelrevised by the lab 2026-06-08, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-C49FE9 | SLU-PP-332 | SLU5GA-01 | 99.236% | 109.2%5.46 of 5 mg | 26 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-63107F | GLP1-S | SM15GA-03 | 98.433% | 114.6%17.19 of 15 mg | 26 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-3AA240 | GHK-Cu | GHK50GA-03 | 98.896% | 108.2%54.09 of 50 mg | 26 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D8D58B | GLA-3 RT | RET10GA-07 | 99.769% | 118.1%11.81 of 10 mg | 25 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-D59632 | DSIP | DS10GA-01 | 99.167% | 110.3%11.03 of 10 mg | 25 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-732DC3 | Glutathione | GLU15GA-03 | 99.3% | 108.4%1626.53 of 1500 mg | 25 May 2026 | PASS | Kovera ↗our verifier → |
| BAC-KVR-2026-AFF1CE | Bacteriostatic Waterbac water certificate | BAC10GA-02 | — | — | 22 May 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-2E9DC5 | Melanotan-1 | MT10GA-04 | 98.601% | 107.9%10.79 of 10 mg | 21 May 2026 | PASSrevised by the lab 2026-05-31, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-046AFE | S-31-S | SS10GA-05 | 99.613% | 118.2%11.82 of 10 mg | 21 May 2026 | PASSover 110% of labelrevised by the lab 2026-05-31, figures unchanged | Kovera ↗our verifier → |
| KVR-2026-50085D | Glow | GLO70GA-02 | 99.909% | 72.9%51.01 of 70 mg | 17 May 2026 | faillab verdict: fail · identity not confirmed · under 90% of label | Kovera ↗our verifier → |
| KVR-2026-40AF14 | GLA-3 RT | RET10GA-04 | 99.899% | — | 11 May 2026 | faillab verdict: fail · identity not confirmed | Kovera ↗our verifier → |
| KVR-2026-2C8A1B | MTP-31 | SS10GA-04 | 99.884% | — | 11 May 2026 | faillab verdict: fail · identity not confirmed | Kovera ↗our verifier → |
| KVR-2026-AEA105 | AHK-Cu | AHRAWGA-01 | — | — | 5 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-290515 | GHK-Cu | GHRAWGA-01 | — | — | 5 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-FBD06A | Selank | SLKGA-03 | — | — | 1 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-65CAC0 | Tesamorelin | TES10GA-07 | — | — | 1 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-C4098E | GLP2-T | TIR60GA-04 | 99.929% | 105.5%63.28 of 60 mg | 30 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-4ABBE6 | Semax | smxga-03 | 99.888% | 123.3%12.33 of 10 mg | 30 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-44EA5D | GLP2-T | TIR30GA-06 | 99.854% | 115.3%34.58 of 30 mg | 30 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4287AA | PT-141 | PT10GA-03 | 99.829% | 98.1%9.81 of 10 mg | 30 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-FE8F85 | TB-500 (Thymosin B4) | TB10GA-02 | 99.929% | 112.1%11.21 of 10 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E32CEC | MOTS-C | MOT10GA-04 | 99.898% | 109.6%10.96 of 10 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E28EE4 | BPC-157/TB-500 | BPTB10GA-04 | 99.861% | 117.5%11.75 of 10 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C9BFAA | AOD-9604 | AOD10GA-01 | 99.862% | 97.2%9.72 of 10 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-BE29CD | CJC-1295 (No DAC)/Ipamorelin | CJIP10GA-04 | 99.893% | 115.7%11.57 of 10 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B177FF | GHK-Cu | GHK100GA-03 | 99.883% | 108.7%108.74 of 100 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-9E4D86 | GLP3-R | RET20GA-03 | 99.856% | 116.9%23.38 of 20 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-2A8197 | Ipamorelin | IPA10GA-03 | 99.913% | 110.9%11.09 of 10 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-250A3B | Melanotan-1 | MT10GA-03 | 99.834% | 118.7%11.87 of 10 mg | 19 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1ED2D0 | 5-Amino-1MQ | 5AM50GA-03 | 99.983% | 108.8%54.39 of 50 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-07BB3D | GLP3-R | RET30GA-06 | 99.893% | 106.3%31.88 of 30 mg | 19 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D525D2 | Melanotan-2 | MT210GA-03 | 99.928% | 110.3%11.03 of 10 mg | 9 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-D49607 | Epithalon | EPI10GA-02 | 99.958% | 134.8%13.48 of 10 mg | 7 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-945E82 | MOTS-c | MOT20GA-04 | 99.923% | 106.8%21.36 of 20 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-15B533 | BPC-157 | BPC20GA-03 | 99.923% | 109.5%21.91 of 20 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F08276 | NAD+ | NADGA-04 | 99.934% | 103.9%519.68 of 500 mg | 4 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E6C80D | Tesamorelin | TES10GA-06 | 99.932% | 107.9%10.79 of 10 mg | 4 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E3A77D | GLA-3 RT | RET10GA-05 | 99.951% | 118.6%11.86 of 10 mg | 4 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-5DB5E9 | GLP1-S | SM15GA-02 | 99.939% | 116.7%17.51 of 15 mg | 4 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| BAC-KVR-2026-8EFB27 | Bacteriostatic Waterbac water certificate | BAC10GA=01 | — | — | 1 Apr 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-FE228C | 5-Amino-1MQ | 5AM10GA-02 | 99.929% | 116.4%11.64 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-FCABA0 | Tesamorelin | TES20GA-03 | 99.922% | 111.0%22.21 of 20 mg | 28 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-882CFD | Klow | KLO80GA-03 | 99.739% | 110.0%88 of 80 mg | 28 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-6F87EF | GLP3-R | RET15GA-02 | 99.979% | 108.8%16.32 of 15 mg | 28 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8859EA | GLP3-R | RET60GA-06 | 99.949% | 105.9%63.56 of 60 mg | 27 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-9B15DA | BPC-157 | BPC10GA-05 | 99.939% | 109.3%10.93 of 10 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5D8D49 | GLP3-R | RET50GA-02 | 99.94% | 94.8%47.38 of 50 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5B0844 | Sermorelin | SER10GA-02 | 99.974% | 115.7%11.57 of 10 mg | 26 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4F00AD | Testagen | TST20GA-02 | 99.928% | 107.0%21.39 of 20 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0D8A68 | GLP3-R | RET10GA-03 | 99.959% | 114.3%11.43 of 10 mg | 26 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4EC6DD | ARA-290 | ARA10GA-01 | 99.986% | 117.9%11.79 of 10 mg | 25 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-24C40B | Cagrilintide | CAG5GA-02 | 99.938% | 113.6%5.68 of 5 mg | 25 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-D37E90 | GLP2-T | TIR20GA-03 | 99.943% | 107.7%21.53 of 20 mg | 24 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-AA3901 | GHKPV | GHKPVGA-01 | 99.712% | 106.6%63.97 of 60 mg | 24 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-936F7A | GLP2-T | TIR10GA-04 | 99.924% | 106.1%10.61 of 10 mg | 24 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D3842A | Methylene Blue (Capsule) | 2026-MBLUE-01 | 99.974% | 109.6%21.92 of 20 mg | 20 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-BD148E | Retatrutide/Cagrilintide | RECA24GA-03 | 99.778% | 104.6%25.1 of 24 mg | 20 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B59DFB | Glutathione | GLU1.5GA-02 | 99.934% | 105.7%1586.24 of 1500 mg | 20 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-63ADE1 | Cartalax | CLX20GA-02 | 99.936% | 108.6%21.72 of 20 mg | 20 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F181B7 | CJC-1295 (No DAC)/Ipamorelin | CJIP10GA-03 | 99.777% | 110.2%11.02 of 10 mg | 13 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E75E1E | Semax/Selank | SXSK10GA-01 | 99.844% | 109.8%21.96 of 20 mg | 13 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D90300 | BPC-157/TB-500 | BPTB20GA-03 | 99.724% | 116.2%23.25 of 20 mg | 13 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A3FE12 | BPC-157 | BPC20GA-02 | 99.971% | 108.4%21.68 of 20 mg | 13 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5D41E5 | Retatrutide | RET20GA-02 | 99.987% | 112.3%22.47 of 20 mg | 13 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-551AB7 | KPV | KPV10GA-03 | 99.922% | 116.1%11.61 of 10 mg | 13 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4C8CEF | SS-31 | MTP10GA-03 | 99.943% | 106.3%10.63 of 10 mg | 13 Mar 2026 | PASS | Kovera ↗our verifier → |
| BAC-KVR-2026-AC70F6 | —bac water certificate | — | — | — | 11 Mar 2026 | NO VERDICT | Kovera ↗our verifier → |
| KVR-2026-C9F7C3 | Kisspeptin-10 | KIS10GA-02 | 99.946% | 110.9%11.09 of 10 mg | 7 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-28702E | Semax | SMXGA-02 | 99.968% | 114.1%11.41 of 10 mg | 6 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B7DB00 | Selank | SLKGA-02 | 99.95% | 111.4%11.14 of 10 mg | 5 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A2ECAD | Ipamorelin | IPA10GA-02 | 99.927% | 109.4%10.94 of 10 mg | 5 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-63E0EC | Tesamorelin/Ipamorelin | TEIPGA-03 | 99.953% | 110.6%14.38 of 13 mg | 5 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1BC9ED | PT-141 | PT10GA-02 | 99.981% | 118.3%11.83 of 10 mg | 5 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E654C3 | Cagrilintide | CAG10GA-03 | 99.931% | 111.4%11.14 of 10 mg | 4 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1D4A0F | GHK-Cu | GHK50GA-02 | 99.854% | 115.8%57.88 of 50 mg | 19 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |